Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for Alopecia Areata
NCT02197455Phase 2Completed
- Sponsor
- Yale University
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib oral solution in alopecia areata, alopecia totalis (AT), alopecia universalis (AU), sponsored by Yale University. Started Jul 2014; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
alopecia areataalopecia totalis (AT)alopecia universalis (AU)
Beyond the preview
Go deeper on NCT02197455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197455.